Hostname: page-component-77c89778f8-9q27g Total loading time: 0 Render date: 2024-07-21T09:35:39.941Z Has data issue: false hasContentIssue false
  • English
  • Français

Electronically Available Comorbid Conditions for Risk Prediction of Healthcare-Associated Clostridium difficile Infection

Published online by Cambridge University Press:  05 February 2018

Anthony D. Harris ,
Alyssa N. Sbarra ,
Surbhi Leekha ,
Sarah S. Jackson ,
J. Kristie Johnson ,
Lisa Pineles  and
Kerri A. Thom
Anthony D. Harris
Affiliation:
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
Alyssa N. Sbarra
Affiliation:
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut
Surbhi Leekha
Affiliation:
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
Sarah S. Jackson
Affiliation:
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
J. Kristie Johnson
Affiliation:
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland
Lisa Pineles
Affiliation:
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
Kerri A. Thom*
Affiliation:
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
*
Address correspondence to Kerri A. Thom, MD, MPH, 655 W Baltimore Street, Bressler Hall M-021, Baltimore, MD 21201 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

OBJECTIVE

To analyze whether electronically available comorbid conditions are risk factors for Centers for Disease Control and Prevention (CDC)-defined, hospital-onset Clostridium difficile infection (CDI) after controlling for antibiotic and gastric acid suppression therapy use.

PATIENTS

Patients aged ≥18 years admitted to the University of Maryland Medical Center between November 7, 2015, and May 31, 2017.

METHODS

Comorbid conditions were assessed using the Elixhauser comorbidity index. The Elixhauser comorbidity index and the comorbid condition components were calculated using the International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) codes extracted from electronic medical records. Bivariate associations between CDI and potential covariates for multivariable regression, including antibiotic use, gastric acid suppression therapy use, as well as comorbid conditions, were estimated using log binomial multivariable regression.

RESULTS

After controlling for antibiotic use, age, proton-pump inhibitor use, and histamine-blocker use, the Elixhauser comorbidity index was a significant risk factor for predicting CDI. There was an increased risk of 1.26 (95% CI, 1.19–1.32) of having CDI for each additional Elixhauser point added to the total Elixhauser score.

CONCLUSIONS

An increase in Elixhauser score is associated with CDI. Our study and other studies have shown that comorbid conditions are important risk factors for CDI. Electronically available comorbid conditions and scores like the Elixhauser index should be considered for risk-adjustment of CDC CDI rates.

Infect Control Hosp Epidemiol 2018;39:297–301

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 39 , Issue 3 , March 2018 , pp. 297 - 301
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. HAI progress report FAQ. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/surveillance/progress-report/faq.html. Updated 2016. Accessed July 31, 2017.Google Scholar
2. Evans, CT, Safdar, N. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clin Infect Dis 2015;60(Suppl 2):S66–S71.Google Scholar
3. Garey, KW, Sethi, S, Yadav, Y, DuPont, HL. Meta-analysis to assess risk factors for recurrent clostridium difficile infection. J Hosp Infect 2008;70:298–304.CrossRefGoogle ScholarPubMed
4. Dial, S, Alrasadi, K, Manoukian, C, Huang, A, Menzies, D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004;171:33–38.Google Scholar
5. Donskey, CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 2004;39:219–226.Google Scholar
6. Khanafer, N, Vanhems, P, Barbut, F, Luxemburger, C, CDI01 Study Group. Factors associated with Clostridium difficile infection: a nested case-control study in a three-year prospective cohort. Anaerobe 2017;44:117–123.Google Scholar
7. Howell, MD, Novack, V, Grgurich, P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170:784–790.CrossRefGoogle ScholarPubMed
8. Dubberke, ER, Reske, KA, Olsen, MA, et al. Risk for Clostridium difficile infection after allogeneic hematopoietic cell transplant remains elevated in the postengraftment period. Transplant Direct 2017;3:e145.Google Scholar
9. Rodemann, JF, Dubberke, ER, Reske, KA, Seo, DH, Stone, CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:339–344.CrossRefGoogle ScholarPubMed
10. Harris, AD, Jackson, SS, Robinson, G, et al. Pseudomonas aeruginosa colonization in the intensive care unit: prevalence, risk factors, and clinical outcomes. Infect Control Hosp Epidemiol 2016;37:544–548.Google Scholar
11. Pepin, CS, Thom, KA, Sorkin, JD, et al. Risk factors for central-line-associated bloodstream infections: a focus on comorbid conditions. Infect Control Hosp Epidemiol 2015;36:479–481.CrossRefGoogle ScholarPubMed
12. Harris, AD, Johnson, JK, Thom, KA, et al. Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting. Infect Control Hosp Epidemiol 2011;32:719–722.Google Scholar
13. Harris, AD, Fleming, B, Bromberg, JS, et al. Surgical site infection after renal transplantation. Infect Control Hosp Epidemiol 2015;36:417–423.Google Scholar
14. Multidrug-resistant organism and Clostridium difficile infection (MDRO/CDI) module. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf. Updated 2017. Accessed July 31, 2017.Google Scholar
15. Quan, H, Sundararajan, V, Halfon, P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130–1139.Google Scholar
16. Elixhauser, A, Steiner, C, Harris, DR, Coffey, RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27.CrossRefGoogle ScholarPubMed
17. Jump, RL. Clostridium difficile infection in older adults. Aging Health 2013;9:403–414.Google Scholar
18. Dudeck, MA, Weiner, LM, Malpiedi, PJ, Edwards, JR, Peterson, KD, Sievert, DM. Risk adjustment for healthcare facility-onset C. difficile and MRSA bacteremia laboratory-identified event reporting in NHSN. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/datastat/riskadjustment-mrsa-cdi.pdf. Published 2013. Accessed July 31, 2017.Google Scholar
19. Jackson, SS, Leekha, S, Magder, LS, et al. Electronically available comorbidities should be used in surgical site infection risk adjustment. Clin Infect Dis 2017;65:803–810.Google Scholar
20. Jackson, SS, Leekha, S, Magder, LS, et al. The effect of adding comorbidities to current centers for disease control and prevention central-line-associated bloodstream infection risk-adjustment methodology. Infect Control Hosp Epidemiol 2017:1–6.Google Scholar
21. Jackson, SS, Leekha, S, Pineles, L, et al. Improving risk adjustment above current centers for disease control and prevention methodology using electronically available comorbid conditions. Infect Control Hosp Epidemiol 2016;37:1173–1178.Google Scholar
22. Datta, R, Kazerouni, NN, Rosenberg, J, et al. Substantial variation in hospital rankings after adjusting for hospital-level predictors of publicly reported hospital-associated clostridium difficile infection rates. Infect Control Hosp Epidemiol 2015;36:464–466.Google Scholar
23. Sexton, DJ, Chen, LF, Moehring, R, Thacker, PA, Anderson, DJ. Casablanca redux: We are shocked that public reporting of rates of central line-associated bloodstream infections are inaccurate. Infect Control Hosp Epidemiol 2012;33:932–935.Google Scholar
24. McGregor, JC, Harris, AD. The need for advancements in the field of risk adjustment for healthcare-associated infections. Infect Control Hosp Epidemiol 2014;35:8–9.Google Scholar
25. Thompson, ND, Edwards, JR, Dudeck, MA, Fridkin, SK, Magill, SS. Evaluating the use of the case mix index for risk adjustment of healthcare-associated infection data: an illustration using Clostridium difficile infection data from the national healthcare safety network. Infect Control Hosp Epidemiol 2016;37:19–25.Google Scholar
26. Quan, H, Parsons, GA, Ghali, WA. Validity of information on comorbidity derived rom ICD-9-CCM administrative data. Med Care 2002;40:675–685.Google Scholar
27. Schneeweiss, S, Maclure, M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000;29:891–898.Google Scholar
28. Quan, H, Li, B, Saunders, LD, et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 2008;43:1424–1441.CrossRefGoogle Scholar
29. Leal, JR, Laupland, KB. Validity of ascertainment of co-morbid illness using administrative databases: a systematic review. Clin Microbiol Infect 2010;16:715–721.Google Scholar